Modification of non-invasive ventilation for the advanced amyotrophic lateral sclerosis patient during the COVID-19 pand...
Published in Journal of the Neurological Sciences
The neurology of COVID-19 revisited: A proposal from the Environmental Neurology Specialty Group of the World Federation...
...Published in Journal of the Neurological Sciences
A comprehensive review of the neurological disorders reported during the current COVID-19 pandemic demonstrates that infection with SARS-CoV-2 affects the central nervous system (CNS), the peripheral nervous system (PNS) and the muscle. CNS manifestations include: headache and decreased responsiveness considered initial indicators of potential neur...
Myasthenic crisis in COVID-19
Published in Journal of the Neurological Sciences
• Myasthenic crises is a potentially severe complication of COVID-19. • Hydroxychloroquine can aggravate myasthenia crises. • IVIg is a potential treatment for both Myasthenic crises and COVID-19. • IVIg treatment may cause thrombosis in susceptible patients.
Covert COVID-19 complications: Continuing the use of evidence-based drugs to minimize potentially lethal indirect effect...
Published in Journal of the Neurological Sciences
Has COVID-19 played an unexpected “stroke” on the chain of survival?
...Published in Journal of the Neurological Sciences
Background The COVID-19 pandemics required several changes in stroke management and it may have influenced some clinical or functional characteristics. We aimed to evaluate the effects of the COVID-19 pandemics on stroke management during the first month of Italy lockdown. In addition, we described the emergency structured pathway adopted by an Ita...
Venous cerebral thrombosis in COVID-19 patient
Published in Journal of the Neurological Sciences
Transient cortical blindness in COVID-19 pneumonia; a PRES-like syndrome: A case report
Published in Journal of the Neurological Sciences
Central nervous system manifestations of COVID-19: A systematic review
Published in Journal of the Neurological Sciences
• Some patients with COVID-19 may show nonspecific neurological symptoms, such as confusion and headache. • A few patients with COVID-19 showed more specific neurological manifestations, such as seizure or cerebrovascular problems. • Neuroinvasion of SARS-CoV2 may partially explain why some patients develop respiratory failure.
Neurotropism of SARS-CoV 2: Mechanisms and manifestations
Published in Journal of the Neurological Sciences
Guidance for the management of myasthenia gravis (MG) and Lambert-Eaton myasthenic syndrome (LEMS) during the COVID-19 p...
...Published in Journal of the Neurological Sciences
